Bioprocess development for a recombinant Mucin-1 fusion protein expressed by CHO cells in protein-free medium
Link T, Backstrom M, Graham R, Essers R, Zörner K, Gätgens J, Burchell J, Taylor-Papadimitriou J, Hansson G, Noll T (2004)
Journal of Biotechnology 110(1): 51-62.
Zeitschriftenaufsatz | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Link, T;
Backstrom, M;
Graham, R;
Essers, R;
Zörner, K;
Gätgens, J;
Burchell, J;
Taylor-Papadimitriou, J;
Hansson, G;
Noll, ThomasUniBi
Einrichtung
Erscheinungsjahr
2004
Zeitschriftentitel
Journal of Biotechnology
Band
110
Ausgabe
1
Seite(n)
51-62
ISSN
0168-1656
Page URI
https://pub.uni-bielefeld.de/record/2395241
Zitieren
Link T, Backstrom M, Graham R, et al. Bioprocess development for a recombinant Mucin-1 fusion protein expressed by CHO cells in protein-free medium. Journal of Biotechnology. 2004;110(1):51-62.
Link, T., Backstrom, M., Graham, R., Essers, R., Zörner, K., Gätgens, J., Burchell, J., et al. (2004). Bioprocess development for a recombinant Mucin-1 fusion protein expressed by CHO cells in protein-free medium. Journal of Biotechnology, 110(1), 51-62. https://doi.org/10.1016/j.jbiotec.2003.12.008
Link, T, Backstrom, M, Graham, R, Essers, R, Zörner, K, Gätgens, J, Burchell, J, Taylor-Papadimitriou, J, Hansson, G, and Noll, Thomas. 2004. “Bioprocess development for a recombinant Mucin-1 fusion protein expressed by CHO cells in protein-free medium”. Journal of Biotechnology 110 (1): 51-62.
Link, T., Backstrom, M., Graham, R., Essers, R., Zörner, K., Gätgens, J., Burchell, J., Taylor-Papadimitriou, J., Hansson, G., and Noll, T. (2004). Bioprocess development for a recombinant Mucin-1 fusion protein expressed by CHO cells in protein-free medium. Journal of Biotechnology 110, 51-62.
Link, T., et al., 2004. Bioprocess development for a recombinant Mucin-1 fusion protein expressed by CHO cells in protein-free medium. Journal of Biotechnology, 110(1), p 51-62.
T. Link, et al., “Bioprocess development for a recombinant Mucin-1 fusion protein expressed by CHO cells in protein-free medium”, Journal of Biotechnology, vol. 110, 2004, pp. 51-62.
Link, T., Backstrom, M., Graham, R., Essers, R., Zörner, K., Gätgens, J., Burchell, J., Taylor-Papadimitriou, J., Hansson, G., Noll, T.: Bioprocess development for a recombinant Mucin-1 fusion protein expressed by CHO cells in protein-free medium. Journal of Biotechnology. 110, 51-62 (2004).
Link, T, Backstrom, M, Graham, R, Essers, R, Zörner, K, Gätgens, J, Burchell, J, Taylor-Papadimitriou, J, Hansson, G, and Noll, Thomas. “Bioprocess development for a recombinant Mucin-1 fusion protein expressed by CHO cells in protein-free medium”. Journal of Biotechnology 110.1 (2004): 51-62.
Daten bereitgestellt von European Bioinformatics Institute (EBI)
23 Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
Investigation of the interactions of critical scale-up parameters (pH, pO2 and pCO2) on CHO batch performance and critical quality attributes.
Brunner M, Fricke J, Kroll P, Herwig C., Bioprocess Biosyst Eng 40(2), 2017
PMID: 27752770
Brunner M, Fricke J, Kroll P, Herwig C., Bioprocess Biosyst Eng 40(2), 2017
PMID: 27752770
Interactions between the breast cancer-associated MUC1 mucins and C-type lectin characterized by optical tweezers.
Hadjialirezaei S, Picco G, Beatson R, Burchell J, Stokke BT, Sletmoen M., PLoS One 12(4), 2017
PMID: 28414807
Hadjialirezaei S, Picco G, Beatson R, Burchell J, Stokke BT, Sletmoen M., PLoS One 12(4), 2017
PMID: 28414807
2D-DIGE screening of high-productive CHO cells under glucose limitation--basic changes in the proteome equipment and hints for epigenetic effects.
Wingens M, Gätgens J, Schmidt A, Albaum SP, Büntemeyer H, Noll T, Hoffrogge R., J Biotechnol 201(), 2015
PMID: 25612871
Wingens M, Gätgens J, Schmidt A, Albaum SP, Büntemeyer H, Noll T, Hoffrogge R., J Biotechnol 201(), 2015
PMID: 25612871
The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL.
Beatson R, Maurstad G, Picco G, Arulappu A, Coleman J, Wandell HH, Clausen H, Mandel U, Taylor-Papadimitriou J, Sletmoen M, Burchell JM., PLoS One 10(5), 2015
PMID: 25951175
Beatson R, Maurstad G, Picco G, Arulappu A, Coleman J, Wandell HH, Clausen H, Mandel U, Taylor-Papadimitriou J, Sletmoen M, Burchell JM., PLoS One 10(5), 2015
PMID: 25951175
A Designed Angiopoietin-1 Variant, Dimeric CMP-Ang1 Activates Tie2 and Stimulates Angiogenesis and Vascular Stabilization in N-glycan Dependent Manner.
Oh N, Kim K, Kim SJ, Park I, Lee JE, Seo YS, An HJ, Kim HM, Koh GY., Sci Rep 5(), 2015
PMID: 26478188
Oh N, Kim K, Kim SJ, Park I, Lee JE, Seo YS, An HJ, Kim HM, Koh GY., Sci Rep 5(), 2015
PMID: 26478188
Analyzing clonal variation of monoclonal antibody-producing CHO cell lines using an in silico metabolomic platform.
Ghorbaniaghdam A, Chen J, Henry O, Jolicoeur M., PLoS One 9(3), 2014
PMID: 24632968
Ghorbaniaghdam A, Chen J, Henry O, Jolicoeur M., PLoS One 9(3), 2014
PMID: 24632968
Modeling of cell culture damage and recovery leads to increased antibody and biomass productivity in CHO cell cultures.
Naderi S, Nikdel A, Meshram M, McConkey B, Ingalls B, Budman H, Scharer J., Biotechnol J 9(9), 2014
PMID: 24852214
Naderi S, Nikdel A, Meshram M, McConkey B, Ingalls B, Budman H, Scharer J., Biotechnol J 9(9), 2014
PMID: 24852214
Breaking limitations of complex culture media: functional non-viral miRNA delivery into pharmaceutical production cell lines.
Fischer S, Wagner A, Kos A, Aschrafi A, Handrick R, Hannemann J, Otte K., J Biotechnol 168(4), 2013
PMID: 23994267
Fischer S, Wagner A, Kos A, Aschrafi A, Handrick R, Hannemann J, Otte K., J Biotechnol 168(4), 2013
PMID: 23994267
A miniaturized bioreactor system for the evaluation of cell interaction with designed substrates in perfusion culture.
Sun T, Donoghue PS, Higginson JR, Gadegaard N, Barnett SC, Riehle MO., J Tissue Eng Regen Med 6 Suppl 3(), 2012
PMID: 22170765
Sun T, Donoghue PS, Higginson JR, Gadegaard N, Barnett SC, Riehle MO., J Tissue Eng Regen Med 6 Suppl 3(), 2012
PMID: 22170765
Laboratory production of human prolactin from CHO cells adapted to serum-free suspension culture.
Arthuso FS, Bartolini P, Soares CR., Appl Biochem Biotechnol 167(8), 2012
PMID: 22692846
Arthuso FS, Bartolini P, Soares CR., Appl Biochem Biotechnol 167(8), 2012
PMID: 22692846
LC-MS-based metabolic characterization of high monoclonal antibody-producing Chinese hamster ovary cells.
Chong WP, Thng SH, Hiu AP, Lee DY, Chan EC, Ho YS., Biotechnol Bioeng 109(12), 2012
PMID: 22711553
Chong WP, Thng SH, Hiu AP, Lee DY, Chan EC, Ho YS., Biotechnol Bioeng 109(12), 2012
PMID: 22711553
The interactions of astrocytes and fibroblasts with defined pore structures in static and perfusion cultures.
Sun T, Donoghue PS, Higginson JR, Gadegaard N, Barnett SC, Riehle MO., Biomaterials 32(8), 2011
PMID: 21163522
Sun T, Donoghue PS, Higginson JR, Gadegaard N, Barnett SC, Riehle MO., Biomaterials 32(8), 2011
PMID: 21163522
Effects of culture temperature and pH on flag-tagged COMP angiopoietin-1 (FCA1) production from recombinant CHO cells: FCA1 aggregation.
Hwang SJ, Yoon SK, Koh GY, Lee GM., Appl Microbiol Biotechnol 91(2), 2011
PMID: 21509567
Hwang SJ, Yoon SK, Koh GY, Lee GM., Appl Microbiol Biotechnol 91(2), 2011
PMID: 21509567
Recombinant glycoprotein E produced in mammalian cells in large-scale as an antigen for varicella-zoster-virus serology.
Thomsson E, Persson L, Grahn A, Snäll J, Ekblad M, Brunhage E, Svensson F, Jern C, Hansson GC, Bäckström M, Bergström T., J Virol Methods 175(1), 2011
PMID: 21540058
Thomsson E, Persson L, Grahn A, Snäll J, Ekblad M, Brunhage E, Svensson F, Jern C, Hansson GC, Bäckström M, Bergström T., J Virol Methods 175(1), 2011
PMID: 21540058
Overcoming challenges in WAVE Bioreactors without feedback controls for pH and dissolved oxygen.
Yuk IH, Baskar D, Duffy PH, Hsiung J, Leung S, Lin AA., Biotechnol Prog 27(5), 2011
PMID: 21987370
Yuk IH, Baskar D, Duffy PH, Hsiung J, Leung S, Lin AA., Biotechnol Prog 27(5), 2011
PMID: 21987370
Studies on substrate utilisation in L-valine-producing Corynebacterium glutamicum strains deficient in pyruvate dehydrogenase complex.
Bartek T, Rudolf C, Kerssen U, Klein B, Blombach B, Lang S, Eikmanns BJ, Oldiges M., Bioprocess Biosyst Eng 33(7), 2010
PMID: 20204663
Bartek T, Rudolf C, Kerssen U, Klein B, Blombach B, Lang S, Eikmanns BJ, Oldiges M., Bioprocess Biosyst Eng 33(7), 2010
PMID: 20204663
Influence of culture conditions on recombinant Drosophila melanogaster S2 cells producing rabies virus glycoprotein cultivated in serum-free medium.
Batista FR, Moraes AM, Büntemeyer H, Noll T., Biologicals 37(2), 2009
PMID: 19059791
Batista FR, Moraes AM, Büntemeyer H, Noll T., Biologicals 37(2), 2009
PMID: 19059791
Expression of aberrantly glycosylated tumor mucin-1 on human DC after transduction with a fiber-modified adenoviral vector.
van Leeuwen EB, Cloosen S, Senden-Gijsbers BL, Agervig Tarp M, Mandel U, Clausen H, Havenga MJ, Duffour MT, García-Vallejo JJ, Germeraad WT, Bos GM., Cytotherapy 8(1), 2006
PMID: 16627342
van Leeuwen EB, Cloosen S, Senden-Gijsbers BL, Agervig Tarp M, Mandel U, Clausen H, Havenga MJ, Duffour MT, García-Vallejo JJ, Germeraad WT, Bos GM., Cytotherapy 8(1), 2006
PMID: 16627342
A new generation of carbohydrate-based therapeutics: recombinant mucin-type fusion proteins as versatile inhibitors of protein-carbohydrate interactions.
Gustafsson A, Holgersson J., Expert Opin Drug Discov 1(2), 2006
PMID: 23495799
Gustafsson A, Holgersson J., Expert Opin Drug Discov 1(2), 2006
PMID: 23495799
Process parameter shifting: Part I. Effect of DOT, pH, and temperature on the performance of Epo-Fc expressing CHO cells cultivated in controlled batch bioreactors.
Trummer E, Fauland K, Seidinger S, Schriebl K, Lattenmayer C, Kunert R, Vorauer-Uhl K, Weik R, Borth N, Katinger H, Müller D., Biotechnol Bioeng 94(6), 2006
PMID: 16736530
Trummer E, Fauland K, Seidinger S, Schriebl K, Lattenmayer C, Kunert R, Vorauer-Uhl K, Weik R, Borth N, Katinger H, Müller D., Biotechnol Bioeng 94(6), 2006
PMID: 16736530
Immune response to Thomsen-Friedenreich disaccharide and glycan engineering.
Irazoqui FJ, Sendra VG, Lardone RD, Nores GA., Immunol Cell Biol 83(4), 2005
PMID: 16033536
Irazoqui FJ, Sendra VG, Lardone RD, Nores GA., Immunol Cell Biol 83(4), 2005
PMID: 16033536
MUC1 as a target antigen for cancer immunotherapy.
Acres B, Limacher JM., Expert Rev Vaccines 4(4), 2005
PMID: 16117706
Acres B, Limacher JM., Expert Rev Vaccines 4(4), 2005
PMID: 16117706
Development of a closed bioreactor system for culture of tissue-engineered skin at an air-liquid interface.
Sun T, Norton D, Haycock JW, Ryan AJ, MacNeil S., Tissue Eng 11(11-12), 2005
PMID: 16411828
Sun T, Norton D, Haycock JW, Ryan AJ, MacNeil S., Tissue Eng 11(11-12), 2005
PMID: 16411828
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 15099905
PubMed | Europe PMC
Suchen in